Q/C Technologies, Inc. Notes Payable, Current
Q/C Technologies, Inc. (QCLS) had Notes Payable, Current of $1.20 million as of 2020-12-31, per its 10-Q/A filed 2021-11-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2021-11-15
- 2020-12-31: Notes Payable, Current $1.20M.
| Period end | Notes Payable, Current |
|---|---|
| 2020-12-31 | $1.20M 10-Q/A · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |